Raqia Therapeutics begins operations in the Harvard Pagliuca Life Labs. Raqia is a new company based on technology developed in the Novina lab. Clinical advisors include Ken Anderson and Nikhil Munshi, who will help translate the BAT-CAR technology for patients with multiple myeloma.